Pre-Clinical Studies of Novel Ras Function Inhibitors to Treat Lung Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/019/30/02

Funding

  • KY Lung Cancer Research Fund: $103,727.00